This was the stock's fourth consecutive day of losses.
Steward Partners Investment Advisory LLC grew its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by ...
Agilent Technologies A is set to report first-quarter fiscal 2025 results on Feb. 26. Find the latest EPS estimates and ...
BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 ...
Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic ...
Agilent Technologies A reported first-quarter fiscal 2025 earnings of $1.31 per share, which beat the Zacks Consensus Estimate by 3.15%. The figure increased 1.6% year over year. Find the latest EPS ...
Agilent Technologies Inc. and Synthego Corp. sparred Friday over whether Agilent patents related to a key component of the ...
Jones Financial Companies Lllp raised its position in Agilent Technologies, Inc. (NYSE:A – Free Report) by 49.0% in the 4th quarter, according to the company in its most recent filing with the ...
The company reported $1.68 billion in revenue at a 25.1% operating margin across its businesses in America, Europe, and Asia.
The stock's fall snapped a three-day winning streak.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU ...